Clinical Trial Update: Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes completed Phase 1/2 studies evaluating whether deprescribing proton pump inhibitors can reduce hepatic encephalopathy afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Proton Pump Inhibitors

Snippet

Sponsor: Duke University | Conditions: Hepatic Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED